Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology; D002713:Chlorine; D003863:Depression / Q000139:chemically induced; D004336:Drug Antagonism; D004357:Drug Synergism; D006801:Humans; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009069:Movement Disorders / Q000139:chemically induced; D009287:Naphthyridines / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical
D002395:Catecholamines; D008781:Methyltyrosines; D009287:Naphthyridines; D010880:Piperidines; D010643:Phenoxybenzamine; D010649:Phenylalanine; D002713:Chlorine; D012110:Reserpine; D000661:Amphetamine; D009638:Norepinephrine